Welcome to our dedicated page for CVS Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on CVS Health stock.
CVS Health Corporation operates an integrated health care model that combines retail pharmacy, pharmacy benefit management, health insurance, medical clinics, specialty and mail pharmacy support, and related consumer health services. Recurring company news includes quarterly results and guidance, segment performance across Health Services, Health Care Benefits, and Pharmacy & Consumer Wellness, and capital returns through common-stock dividends.
Updates also cover CVS Caremark formulary decisions, biosimilar adoption, Aetna prior authorization and plan-administration initiatives, community health investments by the CVS Health Foundation, and developments involving Omnicare, the company's long-term care pharmacy subsidiary.
CVS Health (NYSE: CVS) announced plans to hire 15,000 new employees, focusing on pharmacy technicians, to address the anticipated increase in COVID-19 and flu cases this fall and winter. Over 10,000 positions will be filled at CVS Pharmacy locations, with many being temporary roles that could become permanent. This recruitment drive is part of a larger effort where CVS aims to hire 50,000 employees in response to the pandemic. Job seekers can apply online for various positions, including pharmacists and customer service representatives.
CVS Health (NYSE: CVS) announced its plan to provide COVID-19 vaccinations to long-term care facilities nationwide once the vaccine is available. With experience from administering over nine million flu shots and five million COVID tests, CVS aims to help protect vulnerable elderly populations. The company operates 3,700 drive-thru testing sites and plans to administer approximately four million COVID-19 tests monthly. CEO Larry Merlo emphasized CVS's role in combating COVID-19, showcasing its capabilities to address community health needs effectively.
CVS Health Corporation has announced a quarterly dividend of $0.50 per share, payable on November 2, 2020, to shareholders on record by October 22, 2020. This decision by the board of directors underscores the company's commitment to returning value to its investors. CVS is focused on evolving into a consumer-centric health company, leveraging nearly 10,000 local touchpoints and innovative programs designed to enhance healthcare accessibility and affordability.
Aetna, a CVS Health company, unveiled its 2021 Medicare offerings, focusing on enhanced integration with CVS and new Medicare Advantage plans. Key highlights include the addition of HMO and Dual Eligible Special Needs Plans in new states, as well as Aetna Medicare Eagle plans tailored for Veterans. Aetna also introduced the lowest premium standalone prescription drug plan in the U.S. with an average premium of $7.15. With nearly 9.2 million Medicare members, Aetna aims to provide affordable and convenient care to a broader beneficiary population.
On September 22, 2020, U.S. News & World Report, alongside the Aetna Foundation, unveiled the third annual Healthiest Communities rankings, with new tools tracking COVID-19 data and its effects on community health. The initiative, part of CVS Health’s $100 million commitment to community wellness, emphasizes the disparities worsened by the pandemic. Top-ranked communities include Los Alamos County, New Mexico, and Douglas County, Colorado. The rankings evaluate 3,000 communities based on 84 health metrics across multiple categories.
CVS Health (NYSE: CVS) announced plans to establish over 2,000 new COVID-19 drive-thru test sites, aiming to exceed 4,000 locations by mid-October. This expansion solidifies CVS's position as the operator of the largest number of independent COVID-19 test sites in the U.S., facilitating testing in 33 states and Washington, DC. The tests are self-swabbed at no cost to patients meeting CDC criteria and results are typically available within 2-3 days. CVS emphasizes its commitment to community health and access to essential services during the pandemic.
CVS Health (NYSE: CVS) will invest $13.7 million to renovate 230 low-income housing units at Rosewind apartments in Columbus, Ohio. This initiative is part of the company's broader $600 million commitment over five years to tackle racial inequality and improve social determinants of health. The investment aims to enhance affordable housing access, providing necessary rehab and support programs in the community. Collaborating with local organizations, CVS will also fund health screenings, educational programs, and workforce initiatives to build sustainable community support.
CVS Health announced a special access program for Apple Fitness+, targeting clients, customers, and employees. The plan includes a one-year subscription offer for Aetna commercial and CVS Caremark members, with more details forthcoming. CVS Pharmacy ExtraCare members and current employees will receive a free two-month trial upon the launch of Fitness+. This initiative is part of the ongoing relationship between Aetna and Apple, aimed at enhancing health and wellness for users via a personalized workout experience. Fitness+ integrates metrics from the Apple Watch, making workouts more engaging.
Aetna, a CVS Health company, announced on September 15, 2020, that it will ship "Caring for You" kits to its Medicare Advantage members nationwide. These kits, aimed at supporting members during the COVID-19 pandemic and flu season, will include essential items like thermometers, hand sanitizers, and face masks. Members enrolled by August 1, 2020, will receive these kits at no cost, with shipments beginning the previous week and continuing through fall. Additionally, Aetna is waiving member costs for in-network primary care and telehealth visits until December 31, 2020.
CVS Health announced the expansion of COVID-19 testing to children aged 12 and older at over 2,000 drive-thru test sites, effective September 11, 2020. The initiative responds to the urgent need for testing among minors as schools reopen. CVS has also increased its independent lab partners to expedite test result delivery, which typically takes 2–3 days. Self-swab tests are available at no cost to patients, with registration required in advance. To date, CVS has administered over three million COVID-19 tests since March 2020.